Overview

A Concordance Study Comparing Insulin Treatments in Patients With Type 2 Diabetes

Status:
Completed
Trial end date:
2008-05-01
Target enrollment:
Participant gender:
Summary
A study to compare insulin use and its effect on glucose control and other outcomes in patients with Type 2 diabetes who together with their healthcare provider manage their disease by discussing and agreeing on the diabetes treatment chosen from a selection of available treatment options.
Phase:
Phase 3
Details
Lead Sponsor:
Eli Lilly and Company
Treatments:
Insulin
Insulin, Globin Zinc